๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Carcinogenicity of the Anticancer Topoisomerase Inhibitor, Amsacrine, in Wistar Rats

โœ Scribed by Michael J. Graziano; Cynthia L. Courtney; Earl F. Meierhenry; Thian Kheoh; David G. Pegg; Alex W. Gough

Book ID
115608651
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
978 KB
Volume
32
Category
Article
ISSN
0272-0590

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Application of fluorescence in situ hybr
Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine
โœ Lynnette R. Ferguson; Glenn Whiteside; Karen M. Holdaway; Bruce C. Baguley ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 704 KB

Amsacrine (4'-(9-acridinylamino)methanesulphonm-anisidide) is an antileukemic drug which inhibits topoisomerase I 1 (topo 11) enzymes. We studied effects of two concentrations of amsacrine on the GM101 15A cell line. This is a Chinese hamster line containing a single human chromosome 4, which can be